Back to discover
Disease

Brain Infarction

Late-stage therapeutic developmentEmerging research
2
Publications
13
Clinical trials
2016
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

12 sponsors · 2 new · 0 completed in the last 12 months (net +2)

The current development programme across all trial phases.

Clinical programme
13
All trials
5
Active
8
Late-stage
6
Completed
Late-stage studies
Recruiting
Recently completed

Research activity

2 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20032016
Major themes1
  • Brain Infarction1
Leading journals2
  • European heart journal1
  • The New England journal of medicine1
Leading researchers8
  • Breteler MM1
  • den Heijer T1
  • Herzig R1
  • Hofman A1
  • Hrbáč T1
  • Jonszta T1
  • Koudstaal PJ1
  • Kuliha M1
Affiliations (unnormalised)3
  • Comprehensive Stroke Center1
  • Erasmus Medical Center1
  • Palacký University Olomouc1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Tissue NECROSIS in any area of the brain, including the CEREBRAL HEMISPHERES, the CEREBELLUM, and the BRAIN STEM. Brain infarction is the result of a cascade of events initiated by inadequate blood flow through the brain that is followed by HYPOXIA and HYPOGLYCEMIA in brain tissue. Damage may be temporary, permanent, selective or pan-necrosis.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.